Clinical Trial

Evaluation of HEArt invoLvement in Patients With FABRY Disease

Study acronym: HEAL-FABRY
Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2017-11-29; most recent amendment 2022-07-06.
Trial Details
NCT Number NCT03362164
Lead Sponsor Wuerzburg University Hospital
Collaborators: Competence Network Heart Failure, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), St George's, University of London
Conditions Rare Diseases, Fabry Disease, Fabry Disease, Cardiac Variant, Hypertrophic Cardiomyopathy
Enrollment 650 participants
Start Date 2001-01
Primary Completion 2032-03 (estimated)
Study Completion 2032-03 (estimated)
Updated on ClinicalTrials.gov 2022-07-07